🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
103.61
-2.27 (-2.15%)
Nov 18, 2026, 10:48 AM EST - Market open

Company Description

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.

It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer.

The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development.

In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring.

The company was incorporated in 2015 and is headquartered in Sunnyvale, California.

GRAIL, Inc.
GRAIL logo
CountryUnited States
Founded2016
IndustryDiagnostics & Research
SectorHealthcare
Employees910
CEOJoshua Ofman

Contact Details

Address:
250 S. Mathilda Avenue, Suite 100
Sunnyvale, California 94086
United States
Phone(833) 694-2553
Websitegrail.com

Stock Details

Ticker SymbolGRAL
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code1699031
CUSIP Number384747101
ISIN NumberUS3847471014
Employer ID86-3673636
SIC Code8071

Key Executives

NamePosition
Dr. Joshua J. Ofman M.D., M.S.H.SChief Executive Officer and Director
Aaron FreidinChief Financial Officer and Head of Corporate Development
Robert P. RagusaAdvisor
Paul CiccolellaSenior Vice President of Global Development and Operations
Dr. Satnam Alag Ph.D.Chief Technology Officer
Sir Harpal S. Kumar M.A., M.B.A., MEngChief Scientific Officer and President of Global Clinical and Medical Affairs
Abram Barth J.D., M.P.H.Chief Legal Officer and Corporate Secretary
Trish RowlandSenior Vice President of Corporate Communications
Alison HighlanderChief People Officer
Andrew John PartridgeChief Growth Officer

Latest SEC Filings

DateTypeTitle
Nov 16, 2026144Filing
Nov 10, 2026SCHEDULE 13GFiling
Nov 5, 202610-QQuarterly Report
Nov 5, 2026SCHEDULE 13G/AFiling
Nov 4, 20268-KCurrent Report
Oct 15, 2026144Filing
Oct 5, 2026144Filing
Oct 5, 2026144Filing
Sep 21, 2026144Filing
Aug 27, 2026144Filing